Cassava Sciences to assess Alzheimer’s drug in Phase IIb trial
Alzheimer’s disease is a progressive brain disorder characterised by memory loss. Credit: kalhh from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more